Howard E. Gendelman

Last updated
Howard E. Gendelman, M.D.
BornMarch 18, 1954
Philadelphia, Pennsylvania, USA
NationalityAmerican
Alma mater Muhlenberg College
Pennsylvania State University College of Medicine
Known forHIV research, Parkinson's research, neuroimmune-pharmacology
AwardsStartup of the Year 2022 UNeMed; Nebraska Coalition for Lifesaving Cures' 2022 Life Saver Award; 2018 Jewish Federation of Omaha Humanitarian of the Year Award; 2017 Society on NeuroImmune Pharmacology Lifetime Achievement Award; International Society for NeuroVirology's 2016 Pioneer in NeuroVirology; 2000 J. William Fulbright Research Scholar; and others
Scientific career
FieldsVirology, neuroimmunology, neuroscience, pharmacology, therapeutics
InstitutionsCurrent: University of Nebraska Medical Center
Previous: Henry M. Jackson Foundation for the Advancement in Military Medicine
Walter Reed Army Institute of Research
Uniformed Services University of the Health Sciences Center
Johns Hopkins University
Albert Einstein College of Medicine
Website https://www.unmc.edu/pharmacology/faculty/primary-faculty/gendelman/

Howard E. Gendelman (born March 18, 1954) is an American physician-scientist whose research intersects the disciplines of neuroimmunology, pharmacology, and infectious diseases. Gendelman was born in Philadelphia, Pennsylvania. His research is focused on harnessing immune responses for therapeutic gain in HIV/AIDS and Neurodegenerative disease. [1] He is the Margaret R. Larson Professor of infectious diseases and internal medicine at the University of Nebraska Medical Center (UNMC) in Omaha. [2]

Contents

He is married with three children and seven grandchildren. [3]

Early life and education

Gendelman graduated with a bachelor's degree in Natural Sciences and Russian Studies from Muhlenberg College (1971-1975). [3] He completed his doctorate of medicine at the Pennsylvania State University-Hershey Medical Center (1975-1979). [3] He then completed a residency in Internal medicine at Montefiore Hospital, Albert Einstein College of Medicine (1979-1982), and he was a Clinical and Research Fellow in Neurology and Infectious Diseases at the Johns Hopkins University Medical Center (1982-1985). [3]

Career

Gendelman worked at the National Institute of Allergy and Infectious Diseases during the height of the HIV/AIDS Pandemic. [4] Gendelman also occupied senior faculty and research positions at the Johns Hopkins Medical Institutions, the Uniformed Services University of the Health Sciences Center, the Walter Reed Army Institute of Research, and the Henry M. Jackson Foundation for the Advancement in Military Medicine before joining the faculty of UNMC in March 1993. He retired from the US Army with the rank of Lieutenant Colonel. He established the Center for Neurovirology and Neurodegenerative Disorders at UNMC in 1997, [5] which evolved into UNMC's current Department of Pharmacology and Experimental Neuroscience in 2004. [6] In 2000, he was awarded a Fulbright to do research at the Weizmann Institute of Science in Rehovot, Israel [7] [8]

Research

Mononuclear phagocytes and neurodegenerative disease

Gendelman's research explores the role of mononuclear phagocytes (monocytes, macrophages, microglia, and dendritic cells) as viral reservoirs, perpetrators of disease, and depots for nanoformulated drug delivery. His work was foundational to building a field of investigation focused on lentiviral pathogenesis, diagnostics, and therapeutics. These advancements in immune transformation have led to new and effective management of neurodegenerative disease progression. Gendelman and his research team were among the first to develop laboratory assays for establishing viral tropism for mononuclear phagocytes, and they were the first to demonstrate that infected and immune activated mononuclear phagocytes release viral and cellular toxins that damage the nervous system. [9] [10] [11]

HIV research contributions

Gendelman's group was among the first to reverse HIV-dementia in an infected person using combination antiretroviral therapy (cART), and they developed scores of rodent models to mimic HIV/AIDS end-organ disease. [12] [13] [14] He coined the term long-acting slow effective release ART (LASER ART). These works led to polymer discovery, targeted drug delivery to viral reservoirs, and reduction of residual virus in lymphoid organs. His Nebraska-based research group, along with a team at Temple University, was also the first to combine HIV reservoir-targeted LASER ART and CRISPR-Cas9 to eliminate chronic viral infection from infected animals. [15] This curative approach (published in Nature Communications, 2019) received considerable attention in establishing a novel translational pathway for HIV eradication. [16] [17] [18] This work followed the first ultra-long acting nanocrystal prodrug and the world's first HIV vaccine mimetic [19] [20] (in Nature Materials, 2020). His work with cell-based drug delivery born out of nanoparticle-mononuclear phagocyte interactions has inspired broad pharmaceutical interest; in turn, Gendelman led the establishment of the Nebraska Nanomedicine Production Plant, [21] a biotechnology good manufacturing practices (cGMP) initiative, to position research for clinical translation in the development of long acting nanoformulated ART at UNMC. He also co-founded Exavir Therapeutics, Inc., [22] a biotechnology company developing therapies towards and cure for HIV/AIDS.

Parkinson's Disease research contributions

Gendelman was the first to pharmacologically transform effector into regulatory T cells to halt the progression of Parkinson's disease. [23] [24] Phase II investigation began in early 2021 after successful phase I investigations [25]

Scientific community leadership

Gendelman has written or edited 17 books and monographs (including multiple editions of the textbooks The Neurology of AIDS [26] and Neuroimmune Pharmacology [27] ). He was the founding Editor-in-Chief of the Journal of Neuroimmune Pharmacology.

Awards and honors

Research recognitions

Related Research Articles

This is a timeline of HIV/AIDS, including cases before 1980.

Following infection with HIV-1, the rate of clinical disease progression varies between individuals. Factors such as host susceptibility, genetics and immune function, health care and co-infections as well as viral genetic variability may affect the rate of progression to the point of needing to take medication in order not to develop AIDS.

<span class="mw-page-title-main">Neuroimmune system</span>

The neuroimmune system is a system of structures and processes involving the biochemical and electrophysiological interactions between the nervous system and immune system which protect neurons from pathogens. It serves to protect neurons against disease by maintaining selectively permeable barriers, mediating neuroinflammation and wound healing in damaged neurons, and mobilizing host defenses against pathogens.

<span class="mw-page-title-main">HIV/AIDS</span> Spectrum of conditions caused by HIV infection

Infection with HIV, a retrovirus, can be managed with treatment but without treatment can lead to a spectrum of conditions including AIDS.

The central nervous system (CNS) controls most of the functions of the body and mind. It comprises the brain, spinal cord and the nerve fibers that branch off to all parts of the body. The CNS viral diseases are caused by viruses that attack the CNS. Existing and emerging viral CNS infections are major sources of human morbidity and mortality.

<span class="mw-page-title-main">Janice E. Clements</span> American biologist, academic and medical researcher

Janice Ellen Clements is vice dean for faculty at the Johns Hopkins School of Medicine and the Mary Wallace Stanton Professor of Faculty Affairs. She is a professor in the departments of Molecular and Comparative Pathobiology, Neurology, and Pathology, and has a joint appointment in molecular biology and genetics. Her molecular biology and virology research examines lentiviruses and how they cause neurological diseases.

Opendra "Bill" Narayan was an HIV/AIDS researcher at the Johns Hopkins School of Medicine and the University of Kansas Medical Center. A veterinarian, Narayan researched animal models of HIV. His focus on finding a vaccine for retroviral infection had some success against a monkey retrovirus, SIV, and he is best known for engineering a type of HIV that could cause AIDS-like disease in monkeys.

<span class="mw-page-title-main">Gladstone Institutes</span>

Gladstone Institutes is an independent, non-profit biomedical research organization whose focus is to better understand, prevent, treat and cure cardiovascular, viral and neurological conditions such as heart failure, HIV/AIDS and Alzheimer's disease. Its researchers study these diseases using techniques of basic and translational science. Another focus at Gladstone is building on the development of induced pluripotent stem cell technology by one of its investigators, 2012 Nobel Laureate Shinya Yamanaka, to improve drug discovery, personalized medicine and tissue regeneration.

In biology, a pathogen, in the oldest and broadest sense, is any organism or agent that can produce disease. A pathogen may also be referred to as an infectious agent, or simply a germ.

<span class="mw-page-title-main">HIV/AIDS research</span> Field of immunology research

HIV/AIDS research includes all medical research that attempts to prevent, treat, or cure HIV/AIDS, as well as fundamental research about the nature of HIV as an infectious agent and AIDS as the disease caused by HIV.

Kalipada Pahan is a Professor of Neurological Sciences, Biochemistry and Pharmacology, and the Floyd A. Davis, M.D., Endowed Chair in Neurology at the Rush University Medical Center. He is also a research career scientist at the Department of Veterans Affairs, Jesse Brown VA Medical Center. He is an eminent Indian American neuroscientist involved in translational research on multiple sclerosis, Parkinson's disease, Alzheimer's disease, dementia, and Batten disease. He is well known for his research on statins, cholesterol-lowering drugs. He first explored the application of statins in suppressing the inflammatory events in microglia, astroglia and macrophages. This finding has revolutionized the research on statin drugs. Later, his lab has shown that statins may be beneficial in protecting neurons and improving locomotor activities in Parkinson's disease by suppressing the activation of p21/Ras. His lab is also famous for research on cinnamon where they have described that this commonly-used natural spice may be beneficial for different brain disorders including improving memory and learning of poor learners. Recently his lab has delineated a unique crosstalk between fat and memory in which the lipid-lowering transcription factor PPARalpha controls the formation of hippocampal memory via transcriptional regulation of CREB, suggesting a possible reason for the connection between excess belly fat and memory loss.

Neuroinflammation is inflammation of the nervous tissue. It may be initiated in response to a variety of cues, including infection, traumatic brain injury, toxic metabolites, or autoimmunity. In the central nervous system (CNS), including the brain and spinal cord, microglia are the resident innate immune cells that are activated in response to these cues. The CNS is typically an immunologically privileged site because peripheral immune cells are generally blocked by the blood–brain barrier (BBB), a specialized structure composed of astrocytes and endothelial cells. However, circulating peripheral immune cells may surpass a compromised BBB and encounter neurons and glial cells expressing major histocompatibility complex molecules, perpetuating the immune response. Although the response is initiated to protect the central nervous system from the infectious agent, the effect may be toxic and widespread inflammation as well as further migration of leukocytes through the blood–brain barrier may occur.

M. Juliana “Julie” McElrath is a senior vice president and director of the vaccine and infection disease division at Fred Hutchinson Cancer Research Center and the principal investigator of the HIV Vaccine Trials Network Laboratory Center in Seattle, Washington. She is also a professor at the University of Washington.

<span class="mw-page-title-main">Sharon Lewin</span>

Sharon Ruth Lewin, FRACP, FAHMS is the inaugural Director of The Peter Doherty Institute for Infection and Immunity. She is also a Professor of Medicine at The University of Melbourne, a National Health and Medical Research Council (NHMRC) Practitioner Fellow, Director of the Cumming Global Centre for Pandemic Therapeutics, and President of the International AIDS Society (IAS).

Pontiano Kaleebu is a Ugandan physician, clinical immunologist, HIV/AIDS researcher, academic and medical administrator, who is the executive director of the Uganda Virus Research Institute.

Ya-Chi Ho is a Taiwanese infectious disease researcher and Associate Professor of Microbial Pathogenesis and Medicine at Yale University. Her research centers on the interaction between HIV and the host's immune system with the ultimate goal of curing HIV/AIDS.

Georgette D. Kanmogne is a Cameroonian American geneticist and molecular virologist and a full professor and vice chair for resource allocation and faculty development within the Department of Pharmacology and Experimental Neurosciences at the University of Nebraska Medical Center in Omaha, Nebraska. Kanmogne's research program focuses on exploring the pathogenesis of neuroAIDS by deciphering the mechanisms underlying blood brain barrier dysfunction and viral entry into the central nervous system. Her research also addresses the lack of HIV therapies that cross the blood brain barrier (BBB) and has played a critical role in the development of nanoparticles encapsulating HIV-drugs that can cross the BBB to prevent viral-mediated neuron death in the brain. Kanmogne collaborates with clinical and basic researchers across America, Cameroon, and West Africa, spanning disciplines from hematology to psychiatry, to explore how viral genetic diversity is correlated with the neurological impact of HIV.

Jasmine R. Marcelin is a Caribbean-American infectious disease physician and an Assistant Professor in the Department of Internal Medicine at the University of Nebraska Medical Center (UNMC). Marcelin is also the Associate Medical Director of the Antimicrobial Stewardship Program and as well as the Co-Director of Digital Innovation and Social Media Strategy at UNMC. Marcelin is dedicated to advancing diversity, inclusion, and equity in her communities and is a founding member of the Infectious Diseases Society of America Inclusion, Diversity, Access & Equity Taskforce. Marcelin uses social media to advance medicine, diversity, and patient advocacy and has published articles on how to effectively use social media for these purposes.

Susan Swindells is an American AIDS researcher.

<span class="mw-page-title-main">George Mackaness</span> Australian immunologist (1922–2007)

George Bellamy Mackaness was an Australian professor of microbiology, immunologist, writer and administrator, who researched and described the life history of the macrophage. He showed that by infecting mice with intracellular bacteria, macrophages could be activated to attack other bacteria, triggering further research on "macrophage activation", a term he has come to be associated with.

References

  1. ↑ Johnson, Amanda McGill (2022-01-28). "2022 Luncheon Honoreers". Nebraska Cures. Retrieved 2022-10-26./
  2. ↑ Temple University Health System (2019-07-02). "HIV eliminated from the genomes of living animals". Science Daily=en-US. Retrieved 2022-10-26.
  3. 1 2 3 4 Utesch, Margie (2018-07-03). "Humanitarian of the Year". The Jewish Community Center of Omaha. Retrieved 2021-12-16.
  4. ↑ "Potential new HIV treatment developed at UNMC". KMTV. 2020-04-29. Retrieved 2021-12-16.
  5. ↑ "Front Line (2009)" (PDF). University of Nebraska Medical Center, Department of Pharmacology and Experimental Neuroscience. Retrieved 2022-01-25.
  6. ↑ "About Us". University of Nebraska Medical Center, Department of Pharmacology and Experimental Neuroscience. Retrieved 2022-01-25.
  7. ↑ "UNMC Professor gets Fulbright to study in Israel (2001)". Daily Nebraskan. Retrieved 2022-11-04.
  8. 1 2 "The Pioneer in Neurovirology Award". International Society for NeurVirology. 2016. Retrieved 4 November 2022.
  9. ↑ Adachi, A; Gendelman, H E; Koenig, S; Folks, T; Willey, R; Rabson, A; Martin, M A (August 1986). "Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone". Journal of Virology. 59 (2): 284–291. doi:10.1128/jvi.59.2.284-291.1986. ISSN   0022-538X. PMC   253077 . PMID   3016298. S2CID   12551511.
  10. ↑ Koenig, Scott; Gendelman, Howard E.; Orenstein, Jan M.; Dal Canto, Mauro C.; Pezeshkpour, Gholam H.; Yungbluth, Margaret; Janotta, Frank; Aksamit, Allen; Martin, Malcolm A.; Fauci, Anthony S. (1986-09-05). "Detection of AIDS Virus in Macrophages in Brain Tissue from AIDS Patients with Encephalopathy". Science. 233 (4768): 1089–1093. Bibcode:1986Sci...233.1089K. doi:10.1126/science.3016903. ISSN   0036-8075. PMID   3016903.
  11. ↑ Gendelman, H. E.; Narayan, O.; Molineaux, S.; Clements, J. E.; Ghotbi, Z. (October 1985). "Slow, persistent replication of lentiviruses: role of tissue macrophages and macrophage precursors in bone marrow". Proceedings of the National Academy of Sciences of the United States of America. 82 (20): 7086–7090. Bibcode:1985PNAS...82.7086G. doi: 10.1073/pnas.82.20.7086 . ISSN   0027-8424. PMC   391315 . PMID   2996004.
  12. ↑ Gendelman, Howard E.; Zheng, Jialin; Coulter, Cynthia L.; Ghorpade, Anuja; Che, Myhanh; Thylin, Michael; Rubocki, Ronald; Persidsky, Yuri; Hahn, Francis; Reinhard, Jr., John; Swindells, Susan (October 1998). "Suppression of Inflammatory Neurotoxins by Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus‐Associated Dementia". The Journal of Infectious Diseases. 178 (4): 1000–1007. doi: 10.1086/515693 . ISSN   0022-1899. PMID   9806027. S2CID   42427863.
  13. ↑ Spellman, Lisa (2019-08-09). "Science Cafe explores possibility of HIV cure". University of Nebraska Medical Center. Retrieved 2021-12-16.
  14. ↑ Gendelman, Howard E. (2012). The neurology of AIDS. Oxford University Press. ISBN   978-0-19-539934-9. OCLC   828615707.
  15. ↑ "Scientists say they found a cure for HIV in some mice. Humans could be next". www.washingtonpost.com. Retrieved 2022-11-23.
  16. ↑ "In a first, scientists eliminate HIV from an animal's genome". www.cbsnews.com. Retrieved 2021-12-17.
  17. ↑ Yancey-Bragg, N'dea. "Researchers have eliminated HIV in mice for the first time. Is a cure for humans next?". USA TODAY. Retrieved 2021-12-17.
  18. ↑ Dash, Prasanta K.; Kaminski, Rafal; Bella, Ramona; Su, Hang; Mathews, Saumi; Ahooyi, Taha M.; Chen, Chen; Mancuso, Pietro; Sariyer, Rahsan; Ferrante, Pasquale; Donadoni, Martina (December 2019). "Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice". Nature Communications. 10 (1): 2753. Bibcode:2019NatCo..10.2753D. doi:10.1038/s41467-019-10366-y. ISSN   2041-1723. PMC   6606613 . PMID   31266936.
  19. ↑ Kulkarni, Tanmay A.; Bade, Aditya N.; Sillman, Brady; Shetty, Bhagya Laxmi Dyavar; Wojtkiewicz, Melinda S.; Gautam, Nagsen; Hilaire, James R.; Sravanam, Sruthi; Szlachetka, Adam; Lamberty, Benjamin G.; Morsey, Brenda M. (August 2020). "A year-long extended release nanoformulated cabotegravir prodrug". Nature Materials. 19 (8): 910–920. Bibcode:2020NatMa..19..910K. doi:10.1038/s41563-020-0674-z. ISSN   1476-1122. PMC   7384935 . PMID   32341511.
  20. ↑ Soriano, Vicente; Barreiro, Pablo; de Mendoza, Carmen (August 2020). "Long-acting antiretroviral therapy". Nature Materials. 19 (8): 826–827. Bibcode:2020NatMa..19..826S. doi: 10.1038/s41563-020-0731-7 . ISSN   1476-4660. PMID   32704135. S2CID   220721631.
  21. ↑ "Nebraska Nanomedicine Production Plant | Pharmacology | University of Nebraska Medical Center". www.unmc.edu. Retrieved 2021-12-16.
  22. ↑ "Exavir Therapeutics". exavirtherapeutics.com. 2021-02-14. Retrieved 2021-12-16.
  23. ↑ Benner, Eric J.; Mosley, R. Lee; Destache, Chris J.; Lewis, Travis B.; Jackson-Lewis, Vernice; Gorantla, Santhi; Nemachek, Craig; Green, Steven R.; Przedborski, Serge; Gendelman, Howard E. (2004-06-22). "Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease". Proceedings of the National Academy of Sciences of the United States of America. 101 (25): 9435–9440. Bibcode:2004PNAS..101.9435B. doi: 10.1073/pnas.0400569101 . ISSN   0027-8424. PMC   438994 . PMID   15197276.
  24. ↑ Gendelman, Howard E.; Zhang, Yuning; Santamaria, Pamela; Olson, Katherine E.; Schutt, Charles R.; Bhatti, Danish; Shetty, Bhagya Laxmi Dyavar; Lu, Yaman; Estes, Katherine A.; Standaert, David G.; Heinrichs-Graham, Elizabeth (2017-03-23). "Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson's disease trial". npj Parkinson's Disease. 3 (1): 10. doi:10.1038/s41531-017-0013-5. ISSN   2373-8057. PMC   5445595 . PMID   28649610.
  25. ↑ Olson, Katherine E.; Namminga, Krista L.; Lu, Yaman; Schwab, Aaron D.; Thurston, Mackenzie J.; Abdelmoaty, Mai M.; Kumar, Vikas; Wojtkiewicz, Melinda; Obaro, Helen; Santamaria, Pamela; Mosley, R. Lee (2021-05-01). "Safety, tolerability, and immune-biomarker profiling for year-long sargramostim treatment of Parkinson's disease". EBioMedicine. 67: 103380. doi:10.1016/j.ebiom.2021.103380. ISSN   2352-3964. PMC   8138485 . PMID   34000620.
  26. ↑ Gendelman, Howard E; Grant, Igor; Everall, Ian Paul; Fox, Howard S; Gelbard, Harris A; Lipton, Stuart A; Swindells, Susan, eds. (2012). The Neurology of AIDS. Oxford University Press. doi:10.1093/med/9780195399349.001.0001. ISBN   978-0-19-996519-9.
  27. ↑ Ikezu, Tsuneya; Gendelman, Howard E., eds. (2017). Neuroimmune Pharmacology. doi:10.1007/978-3-319-44022-4. ISBN   978-3-319-44020-0.
  28. ↑ "Innovation Awards". UNeMed.com. 23 October 2022. Retrieved 23 November 2022.
  29. ↑ "2022 Luncheon Honorees". Nebraska Cures. 28 January 2022. Retrieved 28 April 2022.
  30. ↑ "Tribute to Dr. Howard Gendelman and Dr. Bonnie Bloch". YouTube. Nebraska Cures. Retrieved 28 April 2022.
  31. ↑ "SNIP - Society on NeuroImmune Pharmacology". s-nip.org. Retrieved 2021-12-16.
  32. ↑ "$3 Million Grant Recognizes Potential of Research at the UNMC Center for Neurovirology and Neurodegenerative Disorders". University of Nebraska Medical Center. 2001. Retrieved 4 November 2022.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.